Despite such a tolerogenic environment, specific CD8+ T cells directed against HCC antigens have been found in patients and correlated with better survival,12, 13 but their frequency may be too low to efficiently control the disease.14 This evidence concerns the gene CD8A and hepatocellular carcinoma.